The third cycle of the drug price negotiations will involve drugs under Medicare Part B. New prices are set to take effect in ...

the deal was structured so that $50 million of contingent earnout payments were tied to reimbursement rates for iovera based on the following milestones: (1) a payment of $20 million if the CMS ...

I am incredibly grateful for our team's hard work and dedication in reaching this milestone. CMS uses the Hospital Consumer Assessment of Healthcare Providers and Systems Survey to determine and ...